NCT06809608View on ClinicalTrials.gov

A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 13, 2025

Primary Completion Date

June 16, 2025

Study Completion Date

June 16, 2025

Conditions
Healthy Participants
Interventions
DRUG

RO7795081

A single dose will be administered orally per study period (see arm descriptions).

DRUG

Itraconazole

Administered orally (see arm description).

DRUG

Gemfibrozil

Administered orally (see arm description).

DRUG

Cyclosporine

A single dose will be administered orally per study period (see arm descriptions).

Trial Locations (1)

9728 NZ

ICON, Groningen

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT06809608 - A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081 | Biotech Hunter | Biotech Hunter